IMCC
IM Cannabis Corp.NASDAQHealthcare$0.33-2.68%ClosedMarket Cap: $1.0M
As of 2026-04-07
Valuation
P/E (TTM)
—
PEG
—
P/B
4.72
P/S
0.45
EV/EBITDA
-80.47
DCF Value
$-12.11
FCF Yield
-1.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
24.8%
Operating Margin
-51.6%
Net Margin
-3.0%
ROE
-24.4%
ROA
-2.8%
ROIC
-95.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| FY 2025 | $54.7M | 17.7% | $-11.6M | $-11.3M | $-2.67 | — |
| Q3 2025 | $13.9M | 19.7% | $-4.2M | $-3.7M | $-0.75 | — |
| Q2 2025 | $12.7M | 27.0% | $-350.0K | $-309.0K | $-0.09 | — |
| Q1 2025 | $12.5M | 27.6% | $158.0K | $275.0K | $0.09 | — |
| Q4 2024 | $13.3M | 20.1% | $-19.7M | $-1.0M | $-0.43 | — |
| FY 2024 | $54.0M | 15.6% | $-10.2M | $-10.6M | $-4.51 | — |
| Q3 2024 | $13.9M | 22.7% | $953.0K | $-922.0K | $-0.41 | — |
| Q2 2024 | $14.8M | 5.7% | $2.9M | $-3.0M | $-1.38 | — |
| Q1 2024 | $12.1M | 14.7% | $-5.6M | $-5.6M | $-2.52 | — |
| Q4 2023 | $10.7M | 7.9% | $-5.2M | $-3.3M | $-1.48 | — |
| FY 2023 | $48.8M | 20.2% | $-12.8M | $-9.5M | $-4.45 | — |
| Q3 2023 | $12.4M | 21.4% | $-2.3M | $-2.1M | $-0.96 | — |